Association for Cancer Immunotherapy CIMT

@cimt.bsky.social

The Association for Cancer Immunotherapy CIMT is a not-for-profit information and education platform that fosters the development and translation of cancer immunotherapies .

Don't miss PICI Investigator Hideho Okada, MD, PhD (@ucsfhealth) present novel T-cell immunotherapy strategies for resistant gliomas at #CIMT2025. Can i-o crack glioblastoma's notorious defense systems? Find out May 12-14 at Europe's Cancer Immunotherapy Meeting. Register: www.meeting.cimt.eu

CIMT-Meeting

meeting.cimt.eu

Association for Cancer Immunotherapy CIMT@cimt.bsky.social · last yr.

Glioblastomas are notoriously resistant—can T-cell therapies change the game? At #CIMT2025, Dr. Hideho Okada (UC San Francisco, and Parker Institute for Cancer Immunotherapy) will present T-cell-based immunotherapy strategies for malignant gliomas. Register at www.meeting.cimt.eu.

Interested in investigating the principles that regulate the establishment of tumour environments that promote or inhibit the anti-tumour function of the immune system? Our group is currently recruiting a postdoctoral fellow. Learn more about our research 👇 www.cruk.manchester.ac.uk/research-gro...

MI/25/01 – Postdoctoral Scientist – Cancer Inflammation And Immunity Group | Cancer Research UK Manchester Institute

cruk.manchester.ac.uk